DMPA-SC 104 provides similar duration of posttreatment relief from the symptoms of endometriosis as compared with leuprolide acetate
The Effect of Depot Medroxyprogesterone Acetate (DMPA) on Bone Mineral Density (BMD) and Evaluating Changes in BMD After Discontinuation of DMPA in Chinese Women of Reproductive Age
DMPA-SC 104 has significantly less impact on bone mineral density than leuprolide acetate in patients with endometriosis
DMPA, Zalcitabine, and the FDA
DMPA and Breast Cancer: The Dog Has Had Its Day